AbbVie Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
AbbVie Quarterly Cash Flow Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| cash flows from operating activities | 5,153,000,000 | 1,635,000,000 | 7,048,000,000 | 5,447,000,000 | 2,271,000,000 | 4,040,000,000 | 4,753,000,000 | 7,574,000,000 | 6,319,000,000 | 4,193,000,000 | 7,428,000,000 | 7,602,000,000 | 5,005,000,000 | 4,908,000,000 | 5,075,000,000 | 7,935,000,000 | 4,890,000,000 | 4,877,000,000 | 4,854,000,000 | 5,830,000,000 | 3,089,000,000 | 3,815,000,000 | 3,275,000,000 | 4,555,000,000 | 2,477,000,000 | 3,017,000,000 | 3,392,000,000 | 4,524,000,000 | 2,866,000,000 | 2,645,000,000 | 2,584,000,000 | 3,271,000,000 | 2,003,000,000 | 2,102,000,000 | 1,541,000,000 |
| capex | -269,000,000 | -235,000,000 | -291,000,000 | -249,000,000 | -241,000,000 | -193,000,000 | -205,000,000 | -219,000,000 | -178,000,000 | -175,000,000 | -213,000,000 | -177,000,000 | -143,000,000 | -162,000,000 | -187,000,000 | -217,000,000 | -195,000,000 | -188,000,000 | -279,000,000 | -217,000,000 | -177,000,000 | -125,000,000 | -163,000,000 | -154,000,000 | -128,000,000 | -107,000,000 | -123,000,000 | -282,000,000 | -114,000,000 | -119,000,000 | -182,000,000 | -126,000,000 | -126,000,000 | -95,000,000 | -114,000,000 |
| free cash flows | 4,884,000,000 | 1,400,000,000 | 6,757,000,000 | 5,198,000,000 | 2,030,000,000 | 3,847,000,000 | 4,548,000,000 | 7,355,000,000 | 6,141,000,000 | 4,018,000,000 | 7,215,000,000 | 7,425,000,000 | 4,862,000,000 | 4,746,000,000 | 4,888,000,000 | 7,718,000,000 | 4,695,000,000 | 4,689,000,000 | 4,575,000,000 | 5,613,000,000 | 2,912,000,000 | 3,690,000,000 | 3,112,000,000 | 4,401,000,000 | 2,349,000,000 | 2,910,000,000 | 3,269,000,000 | 4,242,000,000 | 2,752,000,000 | 2,526,000,000 | 2,402,000,000 | 3,145,000,000 | 1,877,000,000 | 2,007,000,000 | 1,427,000,000 |
| net earnings | 941,000,000 | 1,289,000,000 | -23,000,000 | 1,564,000,000 | 1,373,000,000 | 1,372,000,000 | 824,000,000 | 1,781,000,000 | 2,027,000,000 | 241,000,000 | 2,472,000,000 | 3,952,000,000 | 928,000,000 | 4,493,000,000 | 4,045,000,000 | 3,180,000,000 | 769,000,000 | 3,555,000,000 | 38,000,000 | 2,313,000,000 | -739,000,000 | 3,010,000,000 | 2,801,000,000 | 1,884,000,000 | 741,000,000 | 2,456,000,000 | -1,826,000,000 | 2,747,000,000 | 1,983,000,000 | 2,783,000,000 | 52,000,000 | 1,631,000,000 | 1,915,000,000 | 1,711,000,000 | 1,391,000,000 |
| adjustments to reconcile net earnings to net cash from operating activities: | |||||||||||||||||||||||||||||||||||
| depreciation | 186,000,000 | 181,000,000 | 206,000,000 | 191,000,000 | 184,000,000 | 183,000,000 | 187,000,000 | 196,000,000 | 190,000,000 | 179,000,000 | 196,000,000 | 181,000,000 | 203,000,000 | 198,000,000 | 173,000,000 | 223,000,000 | 201,000,000 | 206,000,000 | 227,000,000 | 175,000,000 | 149,000,000 | 115,000,000 | 118,000,000 | 114,000,000 | 114,000,000 | 118,000,000 | 122,000,000 | 115,000,000 | 119,000,000 | 115,000,000 | 101,000,000 | 111,000,000 | 110,000,000 | 103,000,000 | 118,000,000 |
| amortization of intangible assets | 1,864,000,000 | 1,858,000,000 | 1,896,000,000 | 1,888,000,000 | 1,947,000,000 | 1,891,000,000 | 1,889,000,000 | 2,039,000,000 | 2,070,000,000 | 1,948,000,000 | 1,961,000,000 | 2,024,000,000 | 1,849,000,000 | 1,855,000,000 | 1,806,000,000 | 1,904,000,000 | 1,999,000,000 | 2,009,000,000 | 1,838,000,000 | 2,117,000,000 | 1,406,000,000 | 444,000,000 | 391,000,000 | 389,000,000 | 388,000,000 | 385,000,000 | 320,000,000 | 320,000,000 | 324,000,000 | 330,000,000 | 268,000,000 | 268,000,000 | 269,000,000 | 271,000,000 | 210,000,000 |
| deferred income taxes | -272,000,000 | -28,000,000 | -767,000,000 | -277,000,000 | -16,000,000 | -389,000,000 | -1,391,000,000 | -863,000,000 | -368,000,000 | -267,000,000 | -516,000,000 | -621,000,000 | -600,000,000 | -194,000,000 | -745,000,000 | -34,000,000 | -91,000,000 | -28,000,000 | -1,827,000,000 | -241,000,000 | |||||||||||||||
| change in fair value of contingent consideration liabilities | 2,795,000,000 | 1,518,000,000 | 279,000,000 | 1,356,000,000 | 1,476,000,000 | 660,000,000 | 1,696,000,000 | 8,000,000 | 1,552,000,000 | 1,872,000,000 | 2,114,000,000 | -214,000,000 | 1,609,000,000 | -748,000,000 | 232,000,000 | 98,000,000 | 2,692,000,000 | -343,000,000 | 4,675,000,000 | 197,000,000 | 809,000,000 | 72,000,000 | 438,000,000 | 180,000,000 | 2,304,000,000 | 169,000,000 | -383,000,000 | 95,000,000 | 485,000,000 | -148,000,000 | 79,000,000 | ||||
| payments of contingent consideration liabilities | -859,000,000 | -549,000,000 | -539,000,000 | -580,000,000 | -485,000,000 | -391,000,000 | -463,000,000 | 234,000,000 | -330,000,000 | -311,000,000 | -315,000,000 | -335,000,000 | -236,000,000 | -246,000,000 | -218,000,000 | -167,000,000 | -181,000,000 | -132,000,000 | -109,000,000 | -83,000,000 | -76,000,000 | -53,000,000 | -43,000,000 | -12,000,000 | 0 | -39,000,000 | 0 | ||||||||
| stock-based compensation | 179,000,000 | 410,000,000 | 164,000,000 | 181,000,000 | 218,000,000 | 348,000,000 | 125,000,000 | 130,000,000 | 179,000,000 | 313,000,000 | 132,000,000 | 126,000,000 | 107,000,000 | 306,000,000 | 129,000,000 | 135,000,000 | 159,000,000 | 269,000,000 | 136,000,000 | 162,000,000 | 236,000,000 | 219,000,000 | 79,000,000 | 75,000,000 | 87,000,000 | 189,000,000 | 70,000,000 | 75,000,000 | 85,000,000 | 191,000,000 | 77,000,000 | 71,000,000 | 76,000,000 | 141,000,000 | 75,000,000 |
| acquired ipr&d and milestones | 823,000,000 | 248,000,000 | 1,574,000,000 | 82,000,000 | 937,000,000 | 164,000,000 | 282,000,000 | 66,000,000 | 280,000,000 | 150,000,000 | 243,000,000 | 40,000,000 | 269,000,000 | 145,000,000 | |||||||||||||||||||||
| non-cash litigation reserve adjustments, net of cash payments | -21,000,000 | -729,000,000 | 167,000,000 | 314,000,000 | -238,000,000 | -87,000,000 | -18,000,000 | 71,000,000 | |||||||||||||||||||||||||||
| other | 79,000,000 | 17,000,000 | 12,000,000 | -22,000,000 | -8,000,000 | -45,000,000 | -6,000,000 | -46,000,000 | -45,000,000 | -128,000,000 | 1,000,000 | -65,000,000 | -214,000,000 | 128,000,000 | -181,000,000 | 87,000,000 | -20,000,000 | 341,000,000 | 57,000,000 | 433,000,000 | 1,000,000 | -49,000,000 | 102,000,000 | 23,000,000 | -33,000,000 | -347,000,000 | 305,000,000 | 17,000,000 | 101,000,000 | 157,000,000 | -207,000,000 | 89,000,000 | 45,000,000 | 103,000,000 | |
| changes in operating assets and liabilities, net of acquisitions: | |||||||||||||||||||||||||||||||||||
| accounts receivable | -17,000,000 | -1,479,000,000 | 387,000,000 | 344,000,000 | 178,000,000 | -702,000,000 | 339,000,000 | 2,000,000 | -80,000,000 | -195,000,000 | -416,000,000 | 357,000,000 | -611,000,000 | -785,000,000 | -749,000,000 | 590,000,000 | -296,000,000 | -866,000,000 | -355,000,000 | -31,000,000 | 482,000,000 | -1,025,000,000 | 133,000,000 | -111,000,000 | 220,000,000 | -316,000,000 | 215,000,000 | -1,000,000 | -124,000,000 | -681,000,000 | -228,000,000 | 4,000,000 | -133,000,000 | -34,000,000 | 58,000,000 |
| inventories | -56,000,000 | -155,000,000 | -128,000,000 | -64,000,000 | -52,000,000 | -75,000,000 | 96,000,000 | -55,000,000 | -273,000,000 | -185,000,000 | -170,000,000 | -17,000,000 | -114,000,000 | -385,000,000 | -112,000,000 | 219,000,000 | -62,000,000 | -187,000,000 | 153,000,000 | 111,000,000 | -197,000,000 | -107,000,000 | 170,000,000 | -113,000,000 | -160,000,000 | -128,000,000 | 141,000,000 | -176,000,000 | -120,000,000 | -71,000,000 | 212,000,000 | -120,000,000 | -70,000,000 | 71,000,000 | -66,000,000 |
| prepaid expenses and other assets | 371,000,000 | -628,000,000 | -100,000,000 | 152,000,000 | 25,000,000 | 284,000,000 | -582,000,000 | 109,000,000 | 452,000,000 | -167,000,000 | -204,000,000 | -74,000,000 | 299,000,000 | -285,000,000 | 265,000,000 | -181,000,000 | 49,000,000 | -330,000,000 | -56,000,000 | -50,000,000 | 259,000,000 | -19,000,000 | -86,000,000 | 280,000,000 | 15,000,000 | -112,000,000 | -73,000,000 | 120,000,000 | -279,000,000 | -267,000,000 | -96,000,000 | 106,000,000 | -75,000,000 | -53,000,000 | -271,000,000 |
| accounts payable and other liabilities | 515,000,000 | -696,000,000 | 1,247,000,000 | 267,000,000 | -1,699,000,000 | 362,000,000 | 179,000,000 | 2,554,000,000 | 1,572,000,000 | -465,000,000 | 1,275,000,000 | 778,000,000 | -190,000,000 | -258,000,000 | 174,000,000 | 1,146,000,000 | 72,000,000 | 236,000,000 | -389,000,000 | 1,437,000,000 | -599,000,000 | 1,065,000,000 | -539,000,000 | 705,000,000 | -1,381,000,000 | 94,000,000 | -691,000,000 | 869,000,000 | -179,000,000 | 191,000,000 | -19,000,000 | 974,000,000 | -264,000,000 | -266,000,000 | -212,000,000 |
| income tax assets and liabilities | -1,375,000,000 | 378,000,000 | -1,803,000,000 | 51,000,000 | -1,834,000,000 | 378,000,000 | 411,000,000 | 33,000,000 | -1,119,000,000 | 187,000,000 | 358,000,000 | 294,000,000 | -548,000,000 | 438,000,000 | -662,000,000 | -66,000,000 | -753,000,000 | 191,000,000 | -275,000,000 | -502,000,000 | |||||||||||||||
| cash flows from investing activities | -1,181,000,000 | -735,000,000 | -1,874,000,000 | -8,256,000,000 | -1,102,000,000 | -9,588,000,000 | -800,000,000 | -369,000,000 | -341,000,000 | -499,000,000 | -448,000,000 | 1,286,000,000 | 130,000,000 | -1,591,000,000 | -1,145,000,000 | -615,000,000 | -242,000,000 | -342,000,000 | -627,000,000 | -1,149,000,000 | -35,652,000,000 | -129,000,000 | -615,000,000 | 1,378,000,000 | -140,000,000 | -27,000,000 | -283,000,000 | -963,000,000 | 687,000,000 | -447,000,000 | 201,000,000 | -109,000,000 | 318,000,000 | -684,000,000 | -119,000,000 |
| acquisitions of businesses, net of cash acquired | 0 | -204,000,000 | |||||||||||||||||||||||||||||||||
| other acquisitions and investments | -940,000,000 | -334,000,000 | -1,792,000,000 | -199,000,000 | -843,000,000 | -190,000,000 | -540,000,000 | -492,000,000 | -278,000,000 | -880,000,000 | -128,000,000 | -80,000,000 | -90,000,000 | ||||||||||||||||||||||
| acquisitions of property and equipment | -269,000,000 | -235,000,000 | -291,000,000 | -249,000,000 | -241,000,000 | -193,000,000 | -205,000,000 | -219,000,000 | -178,000,000 | -175,000,000 | -213,000,000 | -177,000,000 | -143,000,000 | -162,000,000 | -187,000,000 | -217,000,000 | -195,000,000 | -188,000,000 | -279,000,000 | -217,000,000 | -177,000,000 | -125,000,000 | -163,000,000 | -154,000,000 | -128,000,000 | -107,000,000 | -123,000,000 | -282,000,000 | -114,000,000 | -119,000,000 | -182,000,000 | -126,000,000 | -126,000,000 | -95,000,000 | -114,000,000 |
| purchases of investment securities | -12,000,000 | -10,000,000 | -27,000,000 | -24,000,000 | -16,000,000 | -6,000,000 | -34,000,000 | -8,000,000 | -16,000,000 | -19,000,000 | -10,000,000 | -17,000,000 | -5,000,000 | -1,406,000,000 | -46,000,000 | -17,000,000 | -40,000,000 | -16,000,000 | -14,000,000 | -15,000,000 | -19,000,000 | -13,000,000 | -4,000,000 | -21,000,000 | -364,000,000 | -194,000,000 | -211,000,000 | -944,000,000 | -370,000,000 | -267,000,000 | -392,000,000 | -447,000,000 | -421,000,000 | -970,000,000 | -795,000,000 |
| sales and maturities of investment securities | 7,000,000 | 32,000,000 | 39,000,000 | 507,000,000 | 3,000,000 | 6,000,000 | 14,000,000 | 5,000,000 | 14,000,000 | 22,000,000 | 70,000,000 | 1,410,000,000 | 42,000,000 | 8,000,000 | 10,000,000 | 23,000,000 | 54,000,000 | 11,000,000 | 61,000,000 | 35,000,000 | 1,403,000,000 | 26,000,000 | 44,000,000 | 1,589,000,000 | 472,000,000 | 594,000,000 | 246,000,000 | 403,000,000 | 1,200,000,000 | 311,000,000 | 903,000,000 | 544,000,000 | 902,000,000 | 444,000,000 | 780,000,000 |
| cash flows from financing activities | -2,710,000,000 | -1,258,000,000 | -6,861,000,000 | -3,072,000,000 | -6,097,000,000 | 10,819,000,000 | -4,449,000,000 | -2,661,000,000 | -3,920,000,000 | -6,192,000,000 | -9,634,000,000 | -5,518,000,000 | -2,679,000,000 | -6,972,000,000 | -6,338,000,000 | -3,643,000,000 | -5,884,000,000 | -3,174,000,000 | -3,695,000,000 | -2,814,000,000 | -2,570,000,000 | -2,422,000,000 | 26,602,000,000 | -441,000,000 | -2,070,000,000 | -5,383,000,000 | -3,825,000,000 | 916,000,000 | -8,978,000,000 | -2,509,000,000 | -1,928,000,000 | -810,000,000 | -980,000,000 | -1,794,000,000 | -2,502,000,000 |
| net change in commercial paper borrowings with original maturities of three months or less | |||||||||||||||||||||||||||||||||||
| proceeds from issuance of other short-term borrowings | 0 | 0 | 0 | 5,008,000,000 | 0 | 2,000,000 | |||||||||||||||||||||||||||||
| repayments of other short-term borrowings | 0 | 0 | -3,000,000 | -5,005,000,000 | 0 | 0 | 0 | -3,000,000,000 | |||||||||||||||||||||||||||
| proceeds from issuance of long-term debt | 0 | 3,994,000,000 | 2,000,000,000 | 0 | 0 | 14,963,000,000 | 0 | 0 | 0 | 2,000,000,000 | 0 | 0 | 0 | 29,948,000,000 | 0 | 3,856,000,000 | |||||||||||||||||||
| repayments of long-term debt and finance lease obligations | -3,754,000,000 | -3,026,000,000 | -5,762,000,000 | -403,000,000 | -3,345,000,000 | -103,000,000 | -1,794,000,000 | -2,000,000 | -1,002,000,000 | -1,351,000,000 | -6,851,000,000 | -2,701,000,000 | -2,000,000 | -4,879,000,000 | -3,752,000,000 | -2,201,000,000 | -1,269,000,000 | -651,000,000 | -1,531,000,000 | -1,000,000 | |||||||||||||||
| debt issuance costs | -3,000,000 | -20,000,000 | 0 | 0 | 0 | -99,000,000 | 0 | 0 | -176,000,000 | -77,000,000 | -6,000,000 | ||||||||||||||||||||||||
| dividends paid | -2,910,000,000 | -2,925,000,000 | -2,752,000,000 | -2,751,000,000 | -2,750,000,000 | -2,772,000,000 | -2,626,000,000 | -2,627,000,000 | -2,625,000,000 | -2,661,000,000 | -2,506,000,000 | -2,504,000,000 | -2,507,000,000 | -2,526,000,000 | -2,314,000,000 | -2,315,000,000 | -2,310,000,000 | -2,322,000,000 | -2,101,000,000 | -2,100,000,000 | -1,752,000,000 | -1,763,000,000 | -1,595,000,000 | -1,591,000,000 | -1,592,000,000 | -1,588,000,000 | -1,451,000,000 | -1,461,000,000 | -1,531,000,000 | -1,137,000,000 | -1,030,000,000 | -1,026,000,000 | -1,024,000,000 | -1,027,000,000 | -933,000,000 |
| purchases of treasury stock | -12,000,000 | -961,000,000 | -358,000,000 | -17,000,000 | -9,000,000 | -1,324,000,000 | -3,000,000 | -4,000,000 | -10,000,000 | -1,955,000,000 | -4,000,000 | -4,000,000 | -9,000,000 | -1,470,000,000 | -131,000,000 | -6,000,000 | -10,000,000 | -787,000,000 | -296,000,000 | -20,000,000 | -19,000,000 | -643,000,000 | -2,000,000 | -4,000,000 | -3,000,000 | -620,000,000 | -2,058,000,000 | -1,009,000,000 | -7,516,000,000 | -1,431,000,000 | -505,000,000 | -5,000,000 | -5,000,000 | -895,000,000 | -1,824,000,000 |
| proceeds from the exercise of stock options | 5,000,000 | 56,000,000 | 10,000,000 | 67,000,000 | 10,000,000 | 127,000,000 | 31,000,000 | 36,000,000 | 48,000,000 | 65,000,000 | 53,000,000 | 11,000,000 | 70,000,000 | 128,000,000 | 75,000,000 | 25,000,000 | 73,000,000 | 71,000,000 | 100,000,000 | 32,000,000 | 65,000,000 | 12,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | 4,000,000 | 7,000,000 | 2,000,000 | 2,000,000 | 62,000,000 | 40,000,000 | 65,000,000 | 64,000,000 | 85,000,000 | 61,000,000 |
| effect of exchange rate changes on cash and equivalents | 30,000,000 | 9,000,000 | -46,000,000 | 8,000,000 | -9,000,000 | -18,000,000 | 23,000,000 | -16,000,000 | -10,000,000 | 8,000,000 | 23,000,000 | -59,000,000 | -33,000,000 | 7,000,000 | -28,000,000 | -41,000,000 | 27,000,000 | -55,000,000 | 27,000,000 | 6,000,000 | 8,000,000 | -46,000,000 | 14,000,000 | -16,000,000 | 8,000,000 | 1,000,000 | -10,000,000 | -9,000,000 | -35,000,000 | 15,000,000 | 0 | 6,000,000 | 7,000,000 | 16,000,000 | -38,000,000 |
| net change in cash and equivalents | 1,292,000,000 | -349,000,000 | -1,733,000,000 | -5,873,000,000 | -4,937,000,000 | 5,253,000,000 | -473,000,000 | 4,528,000,000 | 2,048,000,000 | -2,490,000,000 | -2,631,000,000 | 3,311,000,000 | 2,423,000,000 | -3,648,000,000 | -2,436,000,000 | 3,636,000,000 | -1,209,000,000 | 1,306,000,000 | 559,000,000 | 1,873,000,000 | -35,125,000,000 | 1,218,000,000 | 29,276,000,000 | 5,476,000,000 | 275,000,000 | -2,392,000,000 | -726,000,000 | 4,468,000,000 | -5,460,000,000 | -296,000,000 | 857,000,000 | 2,358,000,000 | |||
| cash and equivalents, beginning of period | 0 | 5,524,000,000 | 0 | 0 | 12,814,000,000 | 0 | 0 | 9,201,000,000 | 0 | 0 | 9,746,000,000 | 0 | 0 | 8,449,000,000 | 0 | 0 | 39,924,000,000 | 0 | 0 | 7,289,000,000 | 0 | 0 | 9,303,000,000 | 0 | 0 | 5,100,000,000 | |||||||||
| cash and equivalents, end of period | 1,292,000,000 | 5,175,000,000 | -5,873,000,000 | -4,937,000,000 | 18,067,000,000 | 4,528,000,000 | 2,048,000,000 | 6,711,000,000 | 3,311,000,000 | 2,423,000,000 | 6,098,000,000 | 3,636,000,000 | -1,209,000,000 | 9,755,000,000 | 1,873,000,000 | -35,125,000,000 | 41,142,000,000 | 5,476,000,000 | 275,000,000 | 4,897,000,000 | 4,468,000,000 | -5,460,000,000 | 9,007,000,000 | 2,358,000,000 | 1,348,000,000 | 4,740,000,000 | |||||||||
| 2025 form 10-q | | 0 | 5,000,000 | |||||||||||||||||||||||||||||||||
| net change in commercial paper borrowings | 1,593,000,000 | 0 | -306,000,000 | -193,000,000 | -200,000,000 | 699,000,000 | -511,000,000 | ||||||||||||||||||||||||||||
| gain on divestitures | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||
| impairment of intangible assets | 1,405,000,000 | 2,114,000,000 | 0 | 710,000,000 | 0 | ||||||||||||||||||||||||||||||
| acquisition of businesses, net of cash acquired | 0 | -9,199,000,000 | -122,000,000 | 0 | |||||||||||||||||||||||||||||||
| cash and equivalents, beginning of year | |||||||||||||||||||||||||||||||||||
| cash and equivalents, end of year | |||||||||||||||||||||||||||||||||||
| other supplemental information | |||||||||||||||||||||||||||||||||||
| interest paid, net of portion capitalized | |||||||||||||||||||||||||||||||||||
| income taxes paid | |||||||||||||||||||||||||||||||||||
| 55 | |||||||||||||||||||||||||||||||||||
| 2024 form 10-q | | 0 | 0 | 5,000,000 | ||||||||||||||||||||||||||||||||
| other charges related to collaborations | |||||||||||||||||||||||||||||||||||
| acquisitions and investments | -157,000,000 | -160,000,000 | -353,000,000 | -100,000,000 | -209,000,000 | -185,000,000 | -198,000,000 | -12,000,000 | -659,000,000 | -36,000,000 | -120,000,000 | -320,000,000 | -140,000,000 | -29,000,000 | -372,000,000 | -63,000,000 | |||||||||||||||||||
| 2023 form 10-q | | 0 | 0 | 5,000,000 | ||||||||||||||||||||||||||||||||
| supplemental schedule of non-cash investing and financing activities | |||||||||||||||||||||||||||||||||||
| issuance of common shares associated with acquisitions of businesses | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||
| 2022 form 10-q | | 0 | 0 | 5,000,000 | ||||||||||||||||||||||||||||||||
| upfront costs and milestones related to collaborations | 405,000,000 | 902,000,000 | 132,000,000 | 185,000,000 | 348,000,000 | 85,000,000 | 903,000,000 | 40,000,000 | 149,000,000 | 20,000,000 | 126,000,000 | 195,000,000 | 350,000,000 | 55,000,000 | 555,000,000 | 101,000,000 | 385,000,000 | 32,000,000 | 25,000,000 | 28,000,000 | 50,000,000 | ||||||||||||||
| stemcentrx impairment | |||||||||||||||||||||||||||||||||||
| 2021 form 10-q | | 0 | 0 | 5,000,000 | ||||||||||||||||||||||||||||||||
| changes in operating assets and liabilities: | |||||||||||||||||||||||||||||||||||
| intangible asset impairment | 0 | ||||||||||||||||||||||||||||||||||
| impacts related to u.s. tax reform | |||||||||||||||||||||||||||||||||||
| 53 | |||||||||||||||||||||||||||||||||||
| 2020 form 10-q | | 0 | 0 | 6,000,000 | ||||||||||||||||||||||||||||||||
| 48 | 2019 form 10-k | |||||||||||||||||||||||||||||||||||
| 2019 form 10-q | | 0 | 0 | 6,000,000 | ||||||||||||||||||||||||||||||||
| repayments of long-term debt and lease obligations | -1,014,000,000 | -2,008,000,000 | -3,006,000,000 | -7,000,000 | -7,000,000 | -5,000,000 | -7,000,000 | -6,000,000 | -4,004,000,000 | ||||||||||||||||||||||||||
| devaluation loss related to venezuela | 0 | ||||||||||||||||||||||||||||||||||
| 2018 form 10-q | | 0 | 0 | 5,000,000 | ||||||||||||||||||||||||||||||||
| net change in short-term borrowings | -33,000,000 | -401,000,000 | 400,000,000 | 0 | 23,000,000 | 377,000,000 | |||||||||||||||||||||||||||||
| 52 | 2017 form 10-k | |||||||||||||||||||||||||||||||||||
| 2017 form 10-q | | 0 | 0 | 5,000,000 | ||||||||||||||||||||||||||||||||
| change in fair value of contingent consideration | 61,000,000 | 85,000,000 | 85,000,000 | ||||||||||||||||||||||||||||||||
| debt issuance cost | -17,000,000 | ||||||||||||||||||||||||||||||||||
| net decrease in cash and equivalents | -360,000,000 | ||||||||||||||||||||||||||||||||||
| net increase in cash and equivalents | -1,118,000,000 | ||||||||||||||||||||||||||||||||||
| 2016 form 10-q | |
We provide you with 20 years of cash flow statements for AbbVie stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AbbVie stock. Explore the full financial landscape of AbbVie stock with our expertly curated income statements.
The information provided in this report about AbbVie stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.